Anaplasma phagocytophilum (Human Granulocytic Ehrlichiosis) Antibody, Serum
Method Description Describes how the test is performed and provides a method-specific reference
The patient's serum is diluted and is placed in microscopic slide wells which have been coated with Anaplasma phagocytophilum-infected cells. After incubation, the slides are washed and a fluorescein isothiocyanate conjugate is added to each well. The slides are then read using a fluorescence microscope and significant fluorescent staining of intracellular organisms constitutes a positive reaction. (Dumler JS, Asanovich KM, Bakken JS, et al: Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagcoytophilia, and human granulocytic ehrlichia. J Clin Microbiol 1995;33:1098-1103; Pancholi P, Kolbert CP, Mitchell PD, et al: Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 1995;172:1007-1012)
Supplemental Report Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Friday; 9 a.m.